Vivo-Morpholinos: Same oligos, from cultures to critters -


Dysphagia and disrupted cranial nerve development in a mouse model of DiGeorge (22q11) deletion syndrome
Beverly A. Karpinski, Thomas M. Maynard, Matthew S. Fralish, Samer Nuwayhid, Irene E. Zohn, Sally A. Moody, Anthony-S. LaMantia


We assessed feeding-related developmental anomalies in the LgDel mouse model of chromosome 22q11 deletion syndrome (22q11DS), a common developmental disorder that frequently includes perinatal dysphagia – debilitating feeding, swallowing and nutrition difficulties from birth onward – within its phenotypic spectrum. LgDel pups gain significantly less weight during the first postnatal weeks, and have several signs of respiratory infections due to food aspiration. Most 22q11 genes are expressed in anlagen of craniofacial and brainstem regions critical for feeding and swallowing, and diminished expression in LgDel embryos apparently compromises development of these regions. Palate and jaw anomalies indicate divergent oro-facial morphogenesis. Altered expression and patterning of hindbrain transcriptional regulators, especially those related to retinoic acid (RA) signaling, prefigures these disruptions. Subsequently, gene expression, axon growth and sensory ganglion formation in the trigeminal (V), glossopharyngeal (IX) or vagus (X) cranial nerves (CNs) that innervate targets essential for feeding, swallowing and digestion are disrupted. Posterior CN IX and X ganglia anomalies primarily reflect diminished dosage of the 22q11DS candidate gene Tbx1. Genetic modification of RA signaling in LgDel embryos rescues the anterior CN V phenotype and returns expression levels or pattern of RA-sensitive genes to those in wild-type embryos. Thus, diminished 22q11 gene dosage, including but not limited to Tbx1, disrupts oro-facial and CN development by modifying RA-modulated anterior-posterior hindbrain differentiation. These disruptions likely contribute to dysphagia in infants and young children with 22q11DS.


  • Competing interests

    The authors declare no competing financial interests.

  • Author contributions

    B.A.K. and A.-S.L. wrote the manuscript. A.-S.L., S.A.M., T.M.M., I.E.Z. and B.A.K. designed the experiments. B.A.K., T.M.M., A.-S.L. and I.E.Z. performed the experiments. M.S.F. and S.N. bred and maintained mice, collected data and performed primary data analyses. T.M., I.E.Z. and S.A.M. provided rigorous editorial oversight of multiple manuscript drafts.

  • Funding

    This work was supported by NIH grants MH33127 and HD042182 (A.-S.L.), NS23158 and NSF MCB 1121711 (S.A.M.), as well as research enhancement funds from the GW School of Medicine and Health Sciences, Children’s National Medical Center, and the GW Office of the Vice President for Research.

  • Received March 18, 2013.
  • Accepted December 2, 2013.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

View Full Text